Immunovia AB (publ) (STO:IMMNOV)
0.4390
-0.0065 (-1.46%)
Jun 18, 2025, 10:57 AM CET
Immunovia AB Revenue
Immunovia AB had revenue of 139.00K SEK in the quarter ending March 31, 2025, a decrease of -10.90%. This brings the company's revenue in the last twelve months to 914.00K, down -24.53% year-over-year. In the year 2024, Immunovia AB had annual revenue of 931.00K, down -40.89%.
Revenue (ttm)
914.00K
Revenue Growth
-24.53%
P/S Ratio
149.19
Revenue / Employee
101.56K
Employees
9
Market Cap
136.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 931.00K | -644.00K | -40.89% |
Dec 31, 2023 | 1.58M | 430.00K | 37.55% |
Dec 31, 2022 | 1.15M | 301.00K | 35.66% |
Dec 31, 2021 | 844.00K | 482.00K | 133.15% |
Dec 31, 2020 | 362.00K | 6.00K | 1.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
Camurus AB | 2.04B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |
Immunovia AB News
- 3 months ago - Immunovia AB (LTS:0G8X) Q4 2024 Earnings Call Highlights: Breakthroughs in Testing and ... - GuruFocus
- 3 months ago - Q4 2024 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 4 months ago - Immunovia reports Q4 results - Seeking Alpha
- 4 months ago - Immunovia initiates search for a new CFO - Seeking Alpha
- 7 months ago - Q3 2024 Immunovia AB (publ) Earnings Call Transcript - GuruFocus